Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uniqure
Uniqure
(QURE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Glybera
Alipogene tiparvovec
2012-10-25
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alipogene tiparvovec
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemias
Mycophenolate sodium
healthy volunteers/patients
,
graft rejection
,
psychology rejection
,
heart transplantation
,
organ transplantation
,
lupus nephritis
,
systemic lupus erythematosus
,
kidney transplantation
,
epstein-barr virus infections
,
type 1 diabetes mellitus
,
islets of langerhans transplantation
Orgotein
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
Alfacalcidol
prostatic neoplasms
,
peripheral arterial disease
,
atherosclerosis
,
intermittent claudication
,
peripheral vascular diseases
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
chronic kidney disease-mineral and bone disorder
,
neoplasm metastasis
,
chronic renal insufficiency
,
renal insufficiency
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
atopic dermatitis
,
eczema
,
dermatitis
,
type 2 diabetes mellitus
,
kidney transplantation
,
chronic kidney failure
,
kidney diseases
Bevifimod
hypoglycemia
,
chronic renal insufficiency
,
renal insufficiency
,
graft vs host disease
,
anemia
,
heart failure
,
myocardial infarction
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
infarction
,
neoplasms
,
head and neck neoplasms
,
sarcopenia
,
rheumatoid arthritis
,
psoriasis
,
postmenopausal osteoporosis
,
kidney diseases
,
malnutrition
,
chronic kidney failure
,
critical illness
,
burns
,
hyperphosphatemia
,
diabetic nephropathies
,
intraoperative complications
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
acute kidney injury
,
wounds and injuries
,
feeding behavior
,
protein-energy malnutrition
,
muscular atrophy
,
morphological and microscopic findings
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
disease progression
,
gastrointestinal diseases
,
gastroparesis
,
parenteral nutrition
,
protein deficiency
Lotamilast
vasculitis
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
Remetinostat
type 2 diabetes mellitus
,
diabetes mellitus
,
graft rejection
,
hematologic neoplasms
Usistapide
healthy volunteers/patients
,
ulcerative colitis
Solumedrol
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
inflammation
,
blister
,
rheumatoid arthritis
,
arthritis
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
,
lymphoma
,
follicular lymphoma
,
graves ophthalmopathy
,
eye diseases
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
granulomatosis with polyangiitis
,
systemic lupus erythematosus
,
lupus nephritis
,
nephritis
,
pemphigus
,
churg-strauss syndrome
,
systemic vasculitis
,
eosinophilic granuloma
,
hypereosinophilic syndrome
,
syndrome
,
asthma
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
,
pulmonary eosinophilia
,
facial paralysis
,
bell palsy
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use